ConDoR: tumor phylogeny inference with a copy-number constrained mutation loss model
- PMID: 38037115
- PMCID: PMC10688497
- DOI: 10.1186/s13059-023-03106-5
ConDoR: tumor phylogeny inference with a copy-number constrained mutation loss model
Abstract
A tumor contains a diverse collection of somatic mutations that reflect its past evolutionary history and that range in scale from single nucleotide variants (SNVs) to large-scale copy-number aberrations (CNAs). However, no current single-cell DNA sequencing (scDNA-seq) technology produces accurate measurements of both SNVs and CNAs, complicating the inference of tumor phylogenies. We introduce a new evolutionary model, the constrained k-Dollo model, that uses SNVs as phylogenetic markers but constrains losses of SNVs according to clusters of cells. We derive an algorithm, ConDoR, that infers phylogenies from targeted scDNA-seq data using this model. We demonstrate the advantages of ConDoR on simulated and real scDNA-seq data.
Keywords: Cancer; Dollo model; Intra-tumor heterogeneity; Single-cell DNA sequencing; Tumor phylogeny.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Update of
-
ConDoR: Tumor phylogeny inference with a copy-number constrained mutation loss model.bioRxiv [Preprint]. 2023 Jan 6:2023.01.05.522408. doi: 10.1101/2023.01.05.522408. bioRxiv. 2023. Update in: Genome Biol. 2023 Nov 30;24(1):272. doi: 10.1186/s13059-023-03106-5. PMID: 36711528 Free PMC article. Updated. Preprint.
References
-
- Amirouchene-Angelozzi N, Swanton C, Bardelli A. Tumor Evolution as a Therapeutic Target The Impact of Tumor Evolution in Precision Medicine. Cancer Discov. 2017;7(8):805–817. doi: 10.1158/2159-8290.CD-17-0343. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous